W. Barry McDonald

Chairman, Board of Directors

Mr. McDonald has over 40 years of experience in the global health care industry as an operating executive and currently as a founder of McDonald & Associates, a strategic and transactional global health care consultancy/advisory firm. He manages client assignments globally in the medical diagnostics, biopharma, medical device and life science sectors. Mr. McDonald was interim CEO in 2008 and led the effort to find a permanent CEO and remained a Director of TS03 until 2015, a publicly traded Canadian medical device company. He is currently on the Advisory Board of Zeus Scientific, a private US based IVD company.

Prior to his consultancy experience, Mr. McDonald gained his corporate business experience in multiple management roles with Ortho Diagnostics division of J&J, and several divisions of American Hospital Supply (now Baxter). Also, Mr. McDonald was President and CEO of MAST/Hitachi and simultaneously headed an executive sta™ within Hitachi Chemical corporate, which was responsible for new technology assessments, acquisitions, and business development activities for Hitachi Chemical’s life sciences business worldwide. Mr. McDonald’s entrepreneurial experience was gained as President/CEO and Director of Photest Diagnostics, a Company concentrating on novel, homogeneous fluorescent immunoassays for the point-of-care (POC) market. As a venture capital backed emerging Company, he was responsible for the turnaround in Photest, commercialization of its technology, and its ultimate sale to a European corporation.

Mr. McDonald’s academic credentials include an M.D./Ph.D. program at the University of Kentucky, Albert Chandler Medical School, an M.S. in Microbiology and Genetics and a B.S. in Biochemistry and pre-med from The University of Southern Mississippi.